L86P (p.Leu86Pro) variant of AGT (Angiotensinogen)

L86P (p.Leu86Pro) in AGT (Angiotensinogen) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.45 / 1. The record also includes population frequency data and structural context.

L86P (p.Leu86Pro) variant details